Bone health in anorexia nervosa

Current Opinion in Endocrinology, Diabetes and Obesity

Volumn 18, Issue 6, 2011, Pages 376-382

  Misra, Madhusmita ^a,b   Klibanski, Anne ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

anorexia nervosa; bone density; bone microarchitecture; gonadal steroids; growth hormone; insulin like growth factor 1

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; ESTROGEN; PRASTERONE; RECOMBINANT SOMATOMEDIN C; RISEDRONIC ACID; SEROTONIN UPTAKE INHIBITOR; SOMATOMEDIN C; TESTOSTERONE; VITAMIN D;

ANOREXIA NERVOSA; BONE DENSITY; BONE DISEASE; BONE MASS; BONE METABOLISM; ESTROGEN THERAPY; EXERCISE; HORMONE BLOOD LEVEL; HUMAN; HYPERCORTISOLISM; HYPOGONADISM; LEAN BODY WEIGHT; OSSIFICATION; PATHOPHYSIOLOGY; REVIEW; VITAMIN SUPPLEMENTATION; WEIGHT GAIN;

ADOLESCENT; ADULT; ANOREXIA NERVOSA; BONE AND BONES; BONE DENSITY; DIPHOSPHONATES; ESTRADIOL; FRACTURES, BONE; HUMANS; HYPOGONADISM; INSULIN-LIKE GROWTH FACTOR I; OSTEOPOROSIS; WEIGHT GAIN;

EID: 80255136206     PISSN: 1752296X     EISSN: 17522978     Source Type: Journal    
DOI: 10.1097/MED.0b013e32834b4bdc     Document Type: Review

References (65)

1. Misra M, Katzman DK, Cord J, et al. Bone metabolism in adolescent boys with anorexia nervosa. J Clin Endocrinol Metab 2008; 93:3029-3036.
2. Misra M, Prabhakaran R, Miller KK, et al. Weight gain and restoration of menses as predictors of bone mineral density change in adolescent girls with anorexia nervosa-1. J Clin Endocrinol Metab 2008; 93:1231-1237. (Pubitemid 351519715)
3. Misra M, Aggarwal A, Miller KK, et al. Effects of anorexia nervosa on clinical, hematologic, biochemical, and bone density parameters in communitydwelling adolescent girls. Pediatrics 2004; 114:1574-1583. (Pubitemid 41754920)
4. Biller B, Saxe V, Herzog D, et al. Mechanisms of osteoporosis in adult and adolescent women with anorexia nervosa. J Clin Endocrinol Metab 1989; 68:548-554. (Pubitemid 19081427)
5. Wiksten-Almstromer M, Hirschberg AL, Hagenfeldt K. Reduced bone mineral density in adult women diagnosed with menstrual disorders during adolescence. Acta Obstet Gynecol Scand 2009; 88:543-549.
6. Grinspoon S, Thomas E, Pitts S, et al. Prevalence and predictive factors for regional osteopenia in women with anorexia nervosa. Ann Intern Med 2000; 133:790-794.
7. Bredella MA, Fazeli PK, Miller KK, et al. Increased bone marrow fat in anorexia nervosa. J Clin Endocrinol Metab 2009; 94:2129-2136.
8. Fazeli PK, Bredella MA, Misra M, et al. Preadipocyte factor-1 is associated with marrow adiposity and bone mineral density in women with anorexia nervosa. J Clin Endocrinol Metab 2009; 95:407-413.
9. Ecklund K, Vajapeyam S, Feldman HA, et al. Bone marrow changes in adolescent girls with anorexia nervosa. J Bone Miner Res 2009; 25: 298-304.
10. Misra M, Soyka LA, Miller KK, et al. Serum osteoprotegerin in adolescent girls with anorexia nervosa. J Clin Endocrinol Metab 2003; 88:3816-3822. (Pubitemid 37034533)
11. Grinspoon S, Baum H, Lee K, et al. Effects of short-term recombinant human insulin-like growth factor I administration on bone turnover in osteopenic women with anorexia nervosa. J Clin Endocrinol Metab 1996; 81: 3864-3870. (Pubitemid 26380388)
12. Estour B, Germain N, Diconne E, et al. Hormonal profile heterogeneity and short-term physical risk in restrictive anorexia nervosa. J Clin Endocrinol Metab 2010; 95:2203-2210.
13. Bredella MA, Misra M, Miller KK, et al. Distal radius in adolescent girls with anorexia nervosa: trabecular structure analysis with high-resolution flat-panel volume CT. Radiology 2008; 249:938-946.
14. Lawson EA, Miller KK, Bredella MA, et al. Hormone predictors of abnormal bone microarchitecture in women with anorexia nervosa. Bone 2010; 46:458-463.
15. Milos G, Spindler A, Ruegsegger P, et al. Cortical and trabecular bone density and structure in anorexia nervosa. Osteoporos Int 2005; 16:783-790. (Pubitemid 40933594)
16. Walsh CJ, Phan CM, Misra M, et al. Finite Element and trabecular structure analysis in anorexia nervosa via flat-panel volume CT. Radiology 2010; 257:167-174.
17. Miller KK, Lee EE, Lawson EA, et al. Determinants of skeletal loss and recovery in anorexia nervosa. J Clin Endocrinol Metab 2006; 91:2931-2937. (Pubitemid 44271738)
18. Legroux-Gerot I, Vignau J, Collier F, Cortet B. Factors influencing changes in bone mineral density in patients with anorexia nervosa-related osteoporosis: the effect of hormone replacement therapy. Calcif Tissue Int 2008; 83: 315-323.
19. Olmos JM, Valero C, del Barrio AG, et al. Time course of bone loss in patients with anorexia nervosa. Int J Eat Disord 2009; 43:537-542.
20. Soyka LA, Misra M, Frenchman A, et al. Abnormal bone mineral accrual in adolescent girls with anorexia nervosa. J Clin Endocrinol Metab 2002; 87:4177-4185.
21. Misra M, Miller KK, Cord J, et al. Relationships between serum adipokines, insulin levels, and bone density in girls with anorexia nervosa. J Clin Endocrinol Metab 2007; 92:2046-2052. (Pubitemid 46997099)
22. Veldhuis JD, Metzger DL, Martha PM Jr, et al. Estrogen and testosterone, but not a nonaromatizable androgen, direct network integration of the hypothalamo-somatotrope (growth hormone)-insulin-like growth factor I axis in the human: evidence from pubertal pathophysiology and sex-steroid hormone replacement. J Clin Endocrinol Metab 1997; 82:3414-3420. (Pubitemid 27419097)
23. Russell M, Breggia A, Mendes N, et al. Growth hormone is positively associated with surrogate markers of bone turnover during puberty. Clin Endocrinol (Oxf) 2011. [Epub ahead of print]. doi: 10.1111/j.1365-2265.2011. 04088.x
24. Riggs BL, Khosla S, Melton LJ III. Sex steroids and the construction and conservation of the adult skeleton. Endocr Rev 2002; 23:279-302. (Pubitemid 34651948)
25. Miller KK, Lawson EA, Mathur V, et al. Androgens in women with anorexia nervosa and normal-weight women with hypothalamic amenorrhea. J Clin Endocrinol Metab 2007; 92:1334-1339. (Pubitemid 46556406)
26. Misra M, Miller K, Bjornson J, et al. Alterations in growth hormone secretory dynamics in adolescent girls with anorexia nervosa and effects on bone metabolism. J Clin Endocrinol Metab 2003; 88:5615-5623. (Pubitemid 38033024)
27. Counts D, Gwirtsman H, Carlsson L, et al. The effect of anorexia nervosa and refeeding on growth hormone-binding protein, the insulin-like growth factors (IGFs), and the IGF-binding proteins. J Clin Endocrinol Metab 1992; 75: 762-767.
28. Misra M, Miller K, Kuo K, et al. Secretory dynamics of ghrelin in adolescent girls with anorexia nervosa and healthy adolescents. Am J Physiol Endocrinol Metab 2005; 289:E347-E356. (Pubitemid 41076638)
29. Fazeli PK, Misra M, Goldstein M, et al. Fibroblast growth factor-21 may mediate growth hormone resistance in anorexia nervosa. J Clin Endocrinol Metab 2010; 95:369-374.
30. Inagaki T, Lin VY, Goetz R, et al. Inhibition of growth hormone signaling by the fasting-induced hormone FGF21. Cell Metab 2008; 8:77-83.
31. Inagaki T, Dutchak P, Zhao G, et al. Endocrine regulation of the fasting response by PPARalpha-mediated induction of fibroblast growth factor 21. Cell Metab 2007; 5:415-425. (Pubitemid 46825496)
32. Fazeli P, Lawson E, Prabhakaran R, et al. Effects of recombinant human growth hormone in anorexia nervosa: a randomized placebo-controlled study. J Clin Endocrinol Metab 2010; 95:4889-4897.
33. Misra M, Miller KK, Almazan C, et al. Alterations in cortisol secretory dynamics in adolescent girls with anorexia nervosa and effects on bone metabolism. J Clin Endocrinol Metab 2004; 89:4972-4980. (Pubitemid 39391436)
34. Lawson EA, Donoho D, Miller KK, et al. Hypercortisolemia is associated with severity of bone loss and depression in hypothalamic amenorrhea and anorexia nervosa. J Clin Endocrinol Metab 2009; 94:4710-4716.
35. Misra M, Miller KK, Almazan C, et al. Hormonal determinants of regional body composition in adolescent girls with anorexia nervosa and controls. J Clin Endocrinol Metab 2005; 90:2580-2587. (Pubitemid 40686294)
36. Misra M, Miller KK, Kuo K, et al. Secretory dynamics of leptin in adolescent girls with anorexia nervosa and healthy adolescents. Am J Physiol Endocrinol Metab 2005; 289:E373-E381. (Pubitemid 41192692)
37. Germain N, Galusca B, Grouselle D, et al. Ghrelin and obestatin circadian levels differentiate bingeing-purging from restrictive anorexia nervosa. J Clin Endocrinol Metab 2010; 95:3057-3062.
38. Legroux-Gerot I, Vignau J, Biver E, et al. Anorexia nervosa, osteoporosis and circulating leptin: the missing link. Osteoporos Int 2010; 21:1715-1722.
39. Kim SW, Her SJ, Park SJ, et al. Ghrelin stimulates proliferation and differentiation and inhibits apoptosis in osteoblastic MC3T3-E1 cells. Bone 2005; 37:359-369. (Pubitemid 41160494)
40. Maccarinelli G, Sibilia V, Torsello A, et al. Ghrelin regulates proliferation and differentiation of osteoblastic cells. J Endocrinol 2005; 184:249-256. (Pubitemid 40207579)
41. Misra M, Miller KK, Stewart V, et al. Ghrelin and bone metabolism in adolescent girls with anorexia nervosa and healthy adolescents. J Clin Endocrinol Metab 2005; 90:5082-5087. (Pubitemid 41262258)
42. Hamrick MW, Della-Fera MA, Choi YH, et al. Leptin treatment induces loss of bone marrow adipocytes and increases bone formation in leptin-deficient ob/ ob mice. J Bone Miner Res 2005; 20:994-1001. (Pubitemid 40712824)
43. Hamrick MW, Pennington C, Newton D, et al. Leptin deficiency produces contrasting phenotypes in bones of the limb and spine. Bone 2004; 34: 376-383. (Pubitemid 38314902)
44. Misra M, Miller KK, Tsai P, et al. Elevated peptide YY levels in adolescent girls with anorexia nervosa. J Clin Endocrinol Metab 2006; 91:1027-1033. (Pubitemid 43357776)
45. Baldock PA, Sainsbury A, Couzens M, et al. Hypothalamic Y2 receptors regulate bone formation. J Clin Invest 2002; 109:915-921. (Pubitemid 34275112)
46. Utz AL, Lawson EA, Misra M, et al. Peptide YY (PYY) levels and bone mineral density (BMD) in women with anorexia nervosa. Bone 2008; 43:135-139.
47. Bronsky J, Prusa R, Nevoral J. The role of amylin and related peptides in osteoporosis. Clin Chim Acta 2006; 373:9-16. (Pubitemid 44376461)
48. Cornish J, Reid IR. Effects of amylin and adrenomedullin on the skeleton. J Musculoskelet Neuronal Interact 2001; 2:15-24.
49. Wojcik MH, Meenaghan E, Lawson EA, et al. Reduced amylin levels are associated with low bone mineral density in women with anorexia nervosa. Bone 2009; 46:796-800.
50. Luo XH, Guo LJ, Xie H, et al. Adiponectin stimulates RANKL and inhibits OPG expression in human osteoblasts through the MAPK signaling pathway. J Bone Miner Res 2006; 21:1648-1656. (Pubitemid 44484610)
51. Luo XH, Guo LJ, Yuan LQ, et al. Adiponectin stimulates human osteoblasts proliferation and differentiation via the MAPK signaling pathway. Exp Cell Res 2005; 309:99-109.
52. Jurimae J, Jurimae T, Leppik A, Kums T. The influence of ghrelin, adiponectin, and leptin on bone mineral density in healthy postmenopausal women. J Bone Miner Metab 2008; 26:618-623.
53. Jurimae J, Rembel K, Jurimae T, Rehand M. Adiponectin is associated with bone mineral density in perimenopausal women. Horm Metab Res 2005; 37:297-302. (Pubitemid 40896213)
54. Misra M, Le Clair M, Mendes N, et al. 2010. Use of SSRIs may impact bone density in adolescent and young women with anorexia nervosa. CNS Spectr 2010; 15:579-586.
55. Haagensen AL, Feldman HA, Ringelheim J, Gordon CM. Low prevalence of vitamin D deficiency among adolescents with anorexia nervosa. Osteoporos Int 2008; 19:289-294. (Pubitemid 351199188)
56. Klibanski A, Biller B, Schoenfeld D, et al. The effects of estrogen administration on trabecular bone loss in young women with anorexia nervosa. J Clin Endocrinol Metab 1995; 80:898-904.
57. Strokosch GR, Friedman AJ, Wu SC, Kamin M. Effects of an oral contraceptive (norgestimate/ethinyl estradiol) on bone mineral density in adolescent females with anorexia nervosa: a double-blind, placebo-controlled study. J Adolesc Health 2006; 39:819-827. (Pubitemid 44751505)
58. Misra M, Katzman DK, Miller KK, et al. Physiologic estrogen replacement increases bone density in adolescent girls with anorexia nervosa. J Bone Miner Res 2011. [Epub ahead of print] doi: 10.1002/jbmr.447
59. Gordon CM, Grace E, Emans SJ, et al. Effects of oral dehydroepiandrosterone on bone density in young women with anorexia nervosa: a randomized trial. J Clin Endocrinol Metab 2002; 87:4935-4941. (Pubitemid 35316328)
60. Miller KK, Grieco KA, Klibanski A. Testosterone administration in women with anorexia nervosa. J Clin Endocrinol Metab 2005; 90:1428-1433. (Pubitemid 40463999)
61. Miller KK, Meenaghan E, Lawson EA, et al. Effects of risedronate and low-dose transdermal testosterone on bone mineral density in women with anorexia nervosa: a randomized, placebo-controlled study. J Clin Endocrinol Metab 2011; 96:2081-2088.
62. Misra M, McGrane J, Miller KK, et al. Effects of rhIGF-1 administration on surrogate markers of bone turnover in adolescents with anorexia nervosa. Bone 2009; 45:493-498.
63. Grinspoon S, Thomas L, Miller K, et al. Effects of recombinant human IGF-I and oral contraceptive administration on bone density in anorexia nervosa. J Clin Endocrinol Metab 2002; 87:2883-2891. (Pubitemid 34655358)
64. Golden NH, Iglesias EA, Jacobson MS, et al. Alendronate for the treatment of osteopenia in anorexia nervosa: a randomized, double-blind, placebo-controlled trial. J Clin Endocrinol Metab 2005; 90:3179-3185. (Pubitemid 41014272)
65. Waugh EJ, Woodside DB, Beaton DE, et al. Effects of exercise on bone mass in young women with anorexia nervosa. Med Sci Sports Exerc 2010; 43:755-763.